Sodium-glucose co-transporter 2 inhibitors & glucagon-like peptide-1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients.
Tarek MahmoudJude YaganAmal HasanOsama Ashry GheithMohamed MostafaSuzann RidaNabil El-SerwiMohamad ShakerMahmoud KhalidPublished in: Clinical transplantation (2023)
The use of SGLT2i and GLP-1RA appears to be effective and safe in diabetic KTRs with good outcomes. Randomized control trials are required to confirm these findings and establish guidelines.